AHI System

The AHI System by Fifth Eye Inc. is an adjunctive medical technology designed to enhance clinical decision-making by providing non-invasive hemodynamic indicators and a defined decision point related to a patient's circulatory status. It operates by processing physiological data to generate these indicators; however, the specific algorithms, sensor technology, and scientific basis for its measurements and 'decision point' criteria are not detailed in the provided document.

The AHI System, developed by Fifth Eye Inc., is an adjunctive medical device intended to support clinical assessment by providing indicators of a patient's hemodynamic status. Based on its classification information as an 'Adjunctive hemodynamic indicator with decision point,' the system is designed to supplement other monitoring methods, likely through non-invasive means, by offering specific information related to blood flow and circulatory function. It features a 'decision point,' suggesting it provides alerts or defined thresholds based on analyzed physiological data to aid healthcare professionals in recognizing changes or critical levels in monitored hemodynamic parameters, thereby potentially facilitating more timely clinical evaluation or intervention. The provided documentation primarily outlines the device's designated name and regulatory context, and as such, it does not offer in-depth details regarding the specific scientific principles or the precise technological methodology underpinning the AHI System's operation. Information concerning the algorithms used for data processing and indicator generation, the types of physiological signals it analyzes, the specifics of its non-invasive measurement technique, or comprehensive clinical performance results (such as sensitivity and specificity of its decision points) are not contained within this particular text. A full understanding of these aspects, including its clinical efficacy and the science of its measurements, would require access to further technical specifications, scientific publications, or clinical study reports related to the AHI System.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific non-invasive hemodynamic parameters does the AHI System measure or derive (e.g., continuous blood pressure, cardiac output, systemic vascular resistance), and what are their reported accuracies compared to gold-standard invasive methods?; What is the underlying algorithm and data processing methodology used by the AHI System to analyze physiological signals and generate the 'adjunctive hemodynamic indicator' and the 'decision point' thresholds?; For which specific patient populations (e.g., surgical, ICU, septic patients) and clinical settings is the AHI System indicated, and what are the known contraindications or limitations to its use?; What are the validated sensitivity, specificity, positive predictive value, and negative predictive value of the AHI System's 'decision point' for predicting or detecting clinically significant hemodynamic deterioration, as demonstrated in peer-reviewed clinical trials?; How does the AHI System integrate with existing hospital patient monitoring systems and electronic health records, what is the typical learning curve for clinicians, and what are the human factors considerations in its design and deployment?